- Revising Breast Screening Guidelines for Atypical Lesions
- Study Identifies Factors Predicting Long-Term Survival Benefits with Immunotherapy
- Staying Away from Females Leads to Longer Lifespan?
- The first group of people who used the “magic weight-loss drug” are now doing?
- Prolonged Use of Earphones Linked to Irreversible Hearing Loss
- New research challenges traditional understanding of Parkinson’s disease
Whitehouse threatened FDA: Approve COVID-19 Vaccine on Dec 11 or Director Resigns
Whitehouse threatened FDA: Approve COVID-19 Vaccine on Dec 11 or Director Resigns. The White House threatened the Food and Drug Administration to approve the COVID-19 vaccine on the 11th: otherwise the director should resign.
Overseas Network, December 12, US media reported that White House Chief of Staff Mark Meadows told the US Food and Drug Administration (FDA) Commissioner Stephen Hahn on the 11th local time that if the agency ends on the same day If you have not approved the COVID-19 vaccine developed by Pfizer for emergency use, please submit your resignation.
According to the “Washington Post” report on the 11th local time, this warning prompted FDA Commissioner Hahn and the agency to speed up the vaccine approval schedule from Saturday (12th). The New York Times, Axios and Reuters also confirmed the news. Meadows told Hahn that if he does not act quickly to approve the vaccine, he will resign. On the same day, US President Trump also issued threats. Trump posted on social media criticizing the FDA as a “large and slow turtle” in handling vaccines, and warned Hahn that “vaccinations should be taken out now” and “don’t play tricks with me, save lives.”
According to reports, Meadows and Tron’s threats have increased pressure on Hahn and the FDA. Trump once complained that the vaccine was not approved before election day and accused him of “delaying” his re-election. In addition, Trump is dissatisfied that the United Kingdom approved the vaccine before the United States, although Pfizer vaccine has shortened the development and review time.
Hahn said in a statement on Friday (11th) that the FDA has informed Pfizer that after the agency’s advisory committee approved Pfizer vaccine on Thursday (10th), the agency will “quickly complete the final procedure and issue an emergency use authorization.” . In addition, the report pointed out that the FDA also notified the Centers for Disease Control and Prevention (CDC) and the “Action Curvature Rapid Action” project, “so that they can execute the plan and distribute the vaccine in time.”
The US media criticized that this threat once again injected political factors into the vaccine race, which may undermine public trust in vaccines. Since many people in the United States are still unsure whether they will be vaccinated, the vaccine approval process is to show that there are no shortcuts in reviewing the safety and effectiveness of the vaccine.